AI Summary
Researchers have developed a therapy that can effectively kill hypervirulent bacteria such as Klebsiella pneumoniae by penetrating the protective slime they create to resist antibiotics. This treatment, using an antimicrobial peptide from cows, shows promise in treating otherwise incurable infections caused by this bacterium, which can lead to serious health issues such as pneumonia, urinary tract infections, and wound infections. The study's findings are particularly significant for high-risk groups such as seniors and patients with underlying health conditions like diabetes, cancer, kidney failure, and liver disease.
A study has identified a therapy that can penetrate the slime that such infections use to protect themselves from antibiotics. Scientists showed that an antimicrobial peptide from cows has potential for treating incurable infections from the bacterium Klebsiella pneumoniae. The bacteria, commonly found in the intestines, is usually harmless. It becomes a health hazard when it enters other parts of the body and can cause pneumonia, urinary tract and wound infections. Those at highest risk include seniors and patients with other health problems such as diabetes, cancer, kidney failure and liver disease.